Approval · Notice of Compliance 16630 · 2015
VERAFLOX (TABLETS): Notice of Compliance 16630
Issued February 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16630
- Date
- February 24, 2015
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antimicrobial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VERAFLOX (TABLETS) | 02437392 | Marketed |
| VERAFLOX (TABLETS) | 02437406 | Marketed |
| VERAFLOX (TABLETS) | 02437414 | Marketed |
Medicinal ingredients
- PRADOFLOXACIN 15 MG per TAB
- PRADOFLOXACIN 60 MG per TAB
- PRADOFLOXACIN 120 MG per TAB